Tag: Parkinsonism


Pharmacology: Orphenadrine’s Impact on Cognitive Function

Introduction and Chemical Classification Orphenadrine is a pharmaceutical agent classified primarily as an anticholinergic drug, specifically a tertiary amine derivative. Chemically, it is closely related to diphenhydramine and structurally similar to other ethanolamine antihistamines, though its clinical application is centered on its muscle relaxant and antiparkinsonian effects rather than its antihistaminic properties, which are secondary. […]

Read More
Parkinsonism: Beyond the Motor Symptoms

Parkinsonism: Beyond the Motor Symptoms

Introduction and Definition of Parkinsonism Parkinsonism is defined broadly within the field of neurology and psychopathology as a specific clinical syndrome characterized by a constellation of motor symptoms that closely resemble those observed in idiopathic Parkinson’s Disease (PD). Crucially, Parkinsonism is not synonymous with PD; rather, it is the overarching descriptive term for any disorder […]

Read More
PSP: Understanding the Neuropsychological Impact

PSP: Understanding the Neuropsychological Impact

Introduction and Definition Progressive Supranuclear Palsy, often abbreviated as PSP, is a complex and debilitating neurodegenerative disorder belonging to the group of conditions known as atypical parkinsonism. It is fundamentally characterized by the progressive deterioration of specific neural pathways, leading prominently to severe oculomotor palsy, particularly affecting the vertical plane, and profound postural instability. Unlike […]

Read More